I think the opportunity is huge. Reducing counterfeit pharmaceuticals by 1% is worth $2 billion to the pharma industry not to mention saving lives.
It will be interesting to see what it is that they actually bought and how they account for the intangibles. I'm having a tough time imagining what could have been worth $600K if it doesn't include a revenue stream. There is plenty of open source blockchain software to be had.
Once again, it's total BS communication from QMC that leaves lots of very legitimate questions and next to no answers.